Nathaniel (Nate) Lacktman is a partner and chair of the firm’s national Telemedicine & Digital Health Industry Team, and the current Chairman of the Board for the American Telemedicine Association (ATA). He advises entrepreneurial health care providers and technology companies on business arrangements, compliance, and corporate matters in telemedicine, digital health, remote patient monitoring, digital therapeutics, and click-and-mortar services. Working with hospitals, health systems, providers, and start-ups to build telemedicine arrangements across the United States and globally, his practice emphasizes strategic counseling, creative business modeling, and fresh approaches to realize clients’ ambitious and innovative goals.
With more than twenty years’ experience practicing health care law, Nate has been recognized by peer-reviewed industry guides, including the coveted Band 1 Ranking in Chambers USA (2013 – 2025):
- “Nate stands out as the very best in his field of expertise.” “His expertise on telehealth legal and policy issues is second to none. He also cares about how these issues and policies impact real people’s lives.” (2025)
- “His intelligence, analysis, understanding of a client’s industry and ability to craft deliverables in the exact nature required by the client is remarkable.” (2023)
- “He is undoubtedly the foremost authority on telemedicine and direct-to-consumer issues in the country.” “He can problem-solve creatively, and cares about his clients as people.” (2022)
- “He has complete knowledge of a very complicated area of the law … and tremendous business sense.” (2021)
- “A tireless champion for the advancement of the field.” (2019)
- “First of all he’s brilliant.” “He knows the law inside and out and he’s extremely well connected.” (2017)
He has held several leadership positions in the digital health industry, including a seat on HealthTech X’s startup Advisory Council, ATA’s Policy Council, and a former member of the American Board of Telehealth’s inaugural advisory board. He speaks and writes frequently on issues at the forefront of telehealth and is often quoted for his insight about legal and business developments in this area. He has written telehealth legislation across several states, advised on regulations, and drafted comments and policy input to federal and state agencies such as the Drug Enforcement Agency, the Congressional Research Service, state Medicaid Agencies, and state boards of medicine. He has helped write telemedicine policy letters and position statements with such organizations as the ATA and the American Heart Association. He has appeared in publications such as the Wall Street Journal, NPR, CNBC, Fox News, Bloomberg, POLITICO, the Associated Press, Reuters, Modern Healthcare, Forbes, Huffington Post, MobiHealthNews, Wired, Inside Counsel, Buzzfeed, mHealthIntelligence, and Information Week, among others.
